Depressive Disorders - Italy

  • Italy
  • Revenue in the Depressive Disorders market is projected to reach €0.49bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.58%, resulting in a market volume of €0.53bn by 2029.
  • In global comparison, most revenue will be generated in the United States (€5,807.00m in 2024).
  • In relation to total population figures, per person revenues of €179.80 are generated in 2024.

Key regions: India, Europe, Japan, Canada, United Kingdom

 
Marché
 
Région
 
Comparaison de régions
 
Monnaie
 

Analyst Opinion

The Depressive Disorders market in Italy is experiencing significant growth and development.

Customer preferences:
Italian customers are increasingly seeking effective and accessible treatments for depressive disorders. They are looking for therapies that not only alleviate symptoms but also improve their overall well-being. There is a growing demand for personalized treatment options that take into account individual needs and preferences. Additionally, customers are increasingly open to alternative and complementary therapies, such as mindfulness-based interventions and herbal remedies.

Trends in the market:
One of the key trends in the Depressive Disorders market in Italy is the increasing use of digital health solutions. Mobile applications and online platforms that provide mental health support and therapy are gaining popularity. These digital solutions offer convenience and accessibility, allowing individuals to access support and treatment from the comfort of their own homes. The COVID-19 pandemic has further accelerated the adoption of telemedicine and digital health solutions in Italy, as it has highlighted the importance of remote access to healthcare services.Another trend in the market is the growing awareness and destigmatization of mental health issues in Italy. There is a greater recognition of the importance of mental well-being and an increased willingness to seek help for depressive disorders. This has led to an expansion of mental health services and an increase in the number of healthcare professionals specializing in the treatment of depressive disorders.

Local special circumstances:
Italy has a high prevalence of depressive disorders compared to other European countries. This can be attributed to various factors, including the country's economic challenges, high levels of unemployment, and social pressures. The Italian healthcare system is working to address these issues by increasing access to mental health services and implementing policies to reduce the stigma associated with mental health.

Underlying macroeconomic factors:
Italy's economy has been experiencing slow growth in recent years, which has had an impact on the Depressive Disorders market. Economic uncertainties and financial constraints may limit the availability of resources for mental health services and research. However, the government has recognized the importance of mental health and has implemented initiatives to improve access to care and support for individuals with depressive disorders.In conclusion, the Depressive Disorders market in Italy is developing in response to customer preferences for effective and accessible treatments. The market is witnessing a shift towards digital health solutions and a growing awareness of mental health issues. Italy's high prevalence of depressive disorders and economic challenges are also influencing the development of the market.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Vue d’ensemble

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Veuillez patienter

Contact

Des questions ? Nous nous ferons un plaisir de vous aider.
Statista Locations
Contact Camille Dubois
Camille Dubois
Customer Relations

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (États-Unis)

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asie)

Lun - Ven, 9:00 - 17:00 h (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asie)

Lun - Ven, 10:00 - 18:00 h (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Lun - Ven, 9:00 - 18:00 h (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Amérique latine)

Lun - Ven, 9:00 - 18:00 h (EST)